Eric Claassen

9.0k total citations · 1 hit paper
198 papers, 6.9k citations indexed

About

Eric Claassen is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eric Claassen has authored 198 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Immunology, 55 papers in Molecular Biology and 38 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eric Claassen's work include Monoclonal and Polyclonal Antibodies Research (36 papers), Immunotherapy and Immune Responses (27 papers) and Probiotics and Fermented Foods (23 papers). Eric Claassen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (36 papers), Immunotherapy and Immune Responses (27 papers) and Probiotics and Fermented Foods (23 papers). Eric Claassen collaborates with scholars based in Netherlands, United States and Germany. Eric Claassen's co-authors include Nico van Rooijen, Jon D. Laman, W.J.A. Boersma, M. van den Nieuwboer, Randolph J. Noelle, Jan Trapman, Albert O. Brinkmann, C.B.M. Maassen, N. Kors and Cor Berrevoets and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Eric Claassen

198 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgens

1990 772 citations Eric Claassen et al. profile →

Peers

Countries citing papers authored by Eric Claassen

Since Specialization

Citations

This map shows the geographic impact of Eric Claassen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Claassen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Claassen more than expected).

Fields of papers citing papers by Eric Claassen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Claassen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Claassen. The network helps show where Eric Claassen may publish in the future.

Co-authorship network of co-authors of Eric Claassen

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Claassen. A scholar is included among the top collaborators of Eric Claassen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Claassen. Eric Claassen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The pharmaceutical productivity gap – Incremental decline in R&D efficiency despite transient improvements 2024 ·Drug Discovery Today ·(unknown), (unknown), Eric Claassen, Linda van de Burgwal	5
2	An Innovative AI-based primer design tool for precise and accurate detection of SARS-CoV-2 variants of concern 2023 ·Scientific Reports ·(unknown), (unknown), Alberto Tonda, (unknown), Patrick Tabeling, Jessica Vanhomwegen, John MacSharry, (unknown), Lucina Bobadilla‐Morales, Alfredo Corona‐Rivera, Eric Claassen, Johan Garssen, Aletta D. Kraneveld, Alejandro Lopez‐Rincon	2
3	Lower Respiratory Tract Infection Trends in East and South-East Asia: In the Light of Economic and Health Care Development 2021 ·Global Pediatric Health ·(unknown), (unknown), Eric Claassen, Linda van de Burgwal	7
4	Barriers Influencing Vaccine Development Timelines, Identification, Causal Analysis, and Prioritization of Key Barriers by KOLs in General and Covid-19 Vaccine R&D 2021 ·Frontiers in Public Health ·(unknown), (unknown), Eric Claassen, Peter W. M. Hermans, Linda van de Burgwal	10
5	A research agenda to reinforce rabies control: A qualitative and quantitative prioritization 2018 ·PLoS neglected tropical diseases ·(unknown), (unknown), Eric Claassen, Linda van de Burgwal	12
6	Lactobacillus plantarum WCFS 1 and its host interaction: a dozen years after the genome 2016 ·Microbial Biotechnology ·M. van den Nieuwboer, Saskia van Hemert, Eric Claassen, Willem M. de Vos	103
7	Adopting health apps, what's hindering doctors and patients? 2014 ·PLoS ONE ·(unknown), (unknown), (unknown), Eric Claassen	1
8	Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic 2013 ·Beneficial Microbes ·Markus Hell, (unknown), (unknown), Jan Marco Kern, Eric Claassen	47
9	Risk in Vaccine Research and Development Quantified 2013 ·PLoS ONE ·E.S. Pronker, T.C. Weenen, Harry Commandeur, Eric Claassen, (unknown)	169
10	Strain-dependent effects of probiotic lactobacilli on EAE autoimmunity 2008 ·Vaccine ·C.B.M. Maassen, Eric Claassen	64
11	Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development 2003 ·Vaccine ·C.B.M. Maassen, W.J.A. Boersma, Conny van Holten-Neelen, Eric Claassen, Jon D. Laman	78
12	Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions 2000 ·European Journal of Cancer ·R. Maarten Egeler, Blaise E. Favara, Jon D. Laman, Eric Claassen	50
13	Migration of human antigen-presenting cells in a human skin graft onto nude mice model after contact sensitization. 1995 ·PubMed Central ·(unknown), (unknown), W.J.A. Boersma, T van Joost, W.R.F. Notten, Eric Claassen	8
14	Antigen detection in vivo after immunization with different presentation forms of rabies virus antigen: involvement of marginal metallophilic macrophages in the uptake of immune‐stimulating complexes 1995 ·European Journal of Immunology ·Ivo Claassen, Ab Osterhaus, Eric Claassen	23
15	Comparison of adjuvants for immune potentiating properties and side effects in mice 1995 ·Veterinary Immunology and Immunopathology ·Marlies Leenaars, Coenraad Hendriksen, M. A. Koedam, Ivo Claassen, Eric Claassen	32
16	Epitope Mapping and Topology of Baculovirus-Expressed HIV-1 gp160 Determined with a Panel of Murine Monoclonal Antibodies 1994 ·AIDS Research and Human Retroviruses ·Hakan Abacıoğlu, Timothy Fouts, Jon D. Laman, Eric Claassen, Seth H. Pincus, John P. Moore, (unknown), Roberta Kamin‐Lewis, George K. Lewis	164
17	In vivo T-B cell interactions and cytokine-production in the spleen 1994 ·Seminars in Immunology ·Alfons J.M. van den Eertwegh, Jon D. Laman, Randolph J. Noelle, W.J.A. Boersma, Eric Claassen	11
18	A Hidden Region in the Third Variable Domain of HIV-1 IIIB gp120 Identified by a Monoclonal Antibody 1993 ·AIDS Research and Human Retroviruses ·Jon D. Laman, Marc M. Schellekens, George K. Lewis, John P. Moore, Thomas J. Matthews, (unknown), Rob H. Meloen, W.J.A. Boersma, Eric Claassen	18
19	Evaluation of monoclonal antibodies having specificity for human IgG subclasses: results of the 2nd IUIS/WHO collaborative study 1992 ·Immunology Letters ·Roy Jefferis, Charles B. Reimer, F Skvaril, G. G. de Lange, D M Goodall, (unknown), D. J. Phillips, A Vlug, Shigenori Harada, J Rádl, Eric Claassen, (unknown), (unknown)	36
20	Oral administration of TNP-Lactobacillus conjugates in mice: A model for evaluation of mucosal and systemic immune responses and memory formation elicited by transformed lactobacilli 1990 ·Research in Microbiology ·Koen Gerritse, M. Posno, Marc M. Schellekens, W.J.A. Boersma, Eric Claassen	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact